Vitamin C prevents zidovudine-induced NAD(P)H oxidase activation and hypertension in the rat

Cardiovascular Research

Volumn 73, Issue 2, 2007, Pages 432-438

  Papparella, Italia ^a   Ceolotto, Giulio ^a   Berto, Laura ^a   Cavalli, Maurizio ^a   Bova, Sergio ^a   Cargnelli, Gabriella ^a   Ruga, Ezia ^a   Milanesi, Ornella ^a   Franco, Lorenzo ^a   Mazzoni, Martina ^a   Petrelli, Lucia ^a   Nussdorfer, Gastone G ^a   Semplicini, Andrea ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

AZT; Electron microscopy; ESR; Heart; Mitochondria; NAD(P)H oxidase; Protein kinase C

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; DRINKING WATER; PROTEIN KINASE C DELTA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ZIDOVUDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR SYSTEM; ENZYME ACTIVATION; ENZYME SUBUNIT; HEART INJURY; HEART MITOCHONDRION; HOMOGENATE; HYPERTENSION; LONG TERM CARE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTIMETABOLITES; ANTIOXIDANTS; ASCORBIC ACID; BLOTTING, WESTERN; ENZYME ACTIVATION; HYPERTENSION; MALE; MEMBRANE GLYCOPROTEINS; MICROSCOPY, ELECTRON; MYOCYTES, CARDIAC; NADPH OXIDASE; NUCLEAR PROTEINS; PROTEIN KINASE C; RATS; RATS, INBRED WKY; VITAMINS; ZIDOVUDINE;

EID: 33845587217     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.10.010     Document Type: Article

References (44)

1. Volberding P.A., Lagakos S.W., Koch M.A., Pettinelli C., Myers M.W., Booth D.K., et al. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 322 (1990) 941-949
2. Reardon J.E. Human immunodeficiency virus reverse transcriptase: steady-state and pre-steady-state kinetics of nucleotide incorporation. Biochemistry 31 (1992) 4473-4479
3. Brinkman K., ter Hofstede H.J., Burger D.M., Smeitink J.A., and Koopmans P.P. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 12 (1998) 1735-1744
4. Lewis W., Grupp I.L., Grupp G., Hoit B., Morris R., Samarel A.M., et al. Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine. Lab Invest 80 (2000) 187-197
5. Lamperth L., Dalakas M.C., Dagani F., Anderson J., and Ferrari R. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab Invest 65 (1991) 742-751
6. Ruga E., Bova S., Nussdorfer G., Mazzocchi G., Rebuffat P., Milanesi O., et al. Zidovudine-induced alterations in the heart and vascular smooth muscle of the rat. Cardiovasc Res 60 (2003) 147-155
7. De la Asuncion J.G., Del Olmo M.L., Sastre J., Pallardo F.V., and Vina J. Zidovudine (AZT) causes an oxidation of mitochondrial DNA in mouse liver. Hepatology 29 (1999) 985-987
8. Szabados E., Fischer G.M., Toth C.B., Nemeti B., Trombitas K., Habon T., et al. Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Radic Biol Med 26 (1999) 309-317
9. De la Asuncion J.G., Del Olmo M.L., Sastre J., Millan A., Pellin A., Pallardo' F.V., et al. AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins. J Clin Invest 102 (1998) 4-9
10. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86 (2000) 494-501
11. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97 (1996) 1916-1923
12. Griendling K.K., and FitzGerald G.A. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108 (2003) 1912-1916
13. Blokhina O., Virolainen E., and Fagerstedt K.V. Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann Bot (Lond) 91 (2003) 179-194
14. Xiao L., Pimentel D.R., Wang J., Singh K., Colucci W.S., and Sawyer D.B. Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am J Physiol Cell Physiol 282 (2002) C926-C934
15. Papparella I., Ceolotto G., Lenzini L., Mazzoni M., Franco L., Sartori M., et al. Angiotensin II-induced over-activation of p47phox in fibroblasts from hypertensives: which role in the enhanced ERK1/2 responsiveness to angiotensin II?. J Hypertens 23 (2005) 793-800
16. Ceolotto G., Papparella I., Lenzini L., Sartori M., Mazzoni M., Iori E., et al. Insulin generates free radicals in human fibroblasts ex vivo by a protein kinase C-dependent mechanism, which is inhibited by pravastatin. Free Radic Biol Med 41 (2006) 473-483
17. Wheeler S., Maxwell-Bawden A., Herb R.A., Gallagher G.E., and Coast J.R. Zidovudine-induced diaphragmatic contractile dysfunction: impact of an antioxidant diet. Respirology 10 (2005) 171-176
18. Kishi T., Hirooka Y., Kimura Y., Ito K., Shimokawa H., and Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 109 (2004) 2357-2362
19. Piehl L.L., Facorro G.B., Huarte M.G., Desimone M.F., Copello G.J., Diaz L.E., et al. Plasmatic antioxidant capacity due to ascorbate using TEMPO scavenging and electron spin resonance. Clin Chim Acta 359 (2005) 78-88
20. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
21. Babior B.M. NADPH oxidase. Curr Opin Immunol 16 (2004) 42-47
22. Madamanchi N.R., Vendrov A., and Runge M.S. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 29-38
23. Bey E.A., Xu B., Bhattacharjee A., Oldfield C.M., Zhao X., Li Q., et al. Protein kinase C delta is required for p47phox phosphorylation and translocation in activated human monocytes. J Immunol 173 (2004) 5730-5738
24. Taniyama Y., and Griendling K.K. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42 (2003) 1075-1081
25. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 (2000) 840-844
26. Escobales N., and Crespo M.J. Oxidative-nitrosative stress in hypertension. Curr Vasc Pharmacol 3 (2005) 231-246
27. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100 (2000) 2153-2157
28. Mueller C.F., Laude K., McNally J.S., and Harrison D.G. ATVB in focus: redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol 25 (2005) 274-278
29. ATP channels, Gi proteins, phosphatidylinositol 3-kinase and tyrosine kinase. Cardiovasc Res 55 (2002) 544-552
30. Li J.M., Gall N.P., Grieve D.J., Chen M., and Shah A.M. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 40 (2002) 477-484
31. Gorlach A., Brandes R.P., Nguyen K., Amidi M., Dehghani F., and Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87 (2000) 26-32
32. Hanna I.R., Taniyama Y., Szocs K., Rocic P., and Griendling K.K. NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4 (2002) 899-914
33. Lassegue B., and Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285 (2003) R277-R297
34. Li W.G., Stoll L.L., Rice J.B., Xu S.P., Miller Jr. F.J., Chatterjee P., et al. Activation of NAD(P)H oxidase by lipid hydroperoxides: mechanism of oxidant-mediated smooth muscle cytotoxicity. Free Radic Biol Med 34 (2003) 937-946
35. Li W.G., Miller Jr. F.J., Zhang H.J., Spitz D.R., Oberley L.W., and Weintraub N.L. H(2)O(2)-induced O(2) production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J Biol Chem 276 (2001) 29251-29256
36. Ginnan R., and Singer H.A. PKC-delta-dependent pathways contribute to PDGF-stimulated ERK1/2 activation in vascular smooth muscle. Am J Physiol Cell Physiol 288 (2005) C1193-C1201
37. Ishikawa T., Iwasaki E., Kanatani K., Sugino F., Kaneko Y., Obara K., et al. Involvement of novel protein kinase C isoforms in carbachol-stimulated insulin secretion from rat pancreatic islets. Life Sci 77 (2005) 462-469
38. Currier J.S. Cardiovascular risk associated with HIV therapy. J Acquir Immune Defic Syndr 31 (2002) S16-S23
39. Zhan C.D., Sindhu R.K., and Vaziri N.D. Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: reversal by lifelong antioxidant supplementation. Kidney Int 65 (2004) 219-227
40. Payne J.A., Reckelhoff J.F., and Khalil R.A. Role of oxidative stress in age-related reduction of NO-cGMP-mediated vascular relaxation in SHR. Am J Physiol Regul Integr Comp Physiol 285 (2003) R542-R551
41. Hirooka Y., Eshima K., Setoguchi S., Kishi T., Egashira K., and Takeshita A. Vitamin C improves attenuated angiotensin II-induced endothelium-dependent vasodilation in human forearm vessels. Hypertens Res 26 (2003) 953-959
42. Antoniades C., Tousoulis D., Tentolouris C., Toutouzas P., and Stefanadis C. Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice. Herz 28 (2003) 628-638
43. Duarte T.L., and Lunec J. Review: when is an antioxidant not an antioxidant? A review of novel actions and reactions of vitamin C. Free Radic Res 39 (2005) 671-686
44. Ulker S., McKeown P.P., and Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 41 (2003) 534-539